Overview

Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude

Status:
Unknown status
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
Open-labeled, Prospective, Randomized, Multi-center, Interventional, Phase IV study.
Phase:
Phase 4
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited
Treatments:
Entecavir